CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody–associated vasculitis

CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody–associated vasculitis

Abstract Objective The present cohort study aimed to evaluate the value of CCL23 in diagnosis, disease activity, and prognosis in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Methods CCL23 levels in serum samples from 317 patients with AAV and 83 healthy controls (H...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiwei Hao, Qianqian Liu, Xiaoping Li, Yiran Xu, Wenjuan Guan, Lei Zhang, Fang Dong, Wenjun Cao, Shengyun Liu, Wei Li
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Arthritis Research & Therapy
Subjects:
ANCA-associated vasculitis
CCL23
Biomarker
Renal involvement
Prognosis
Online Access:https://doi.org/10.1186/s13075-025-03552-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13075-025-03552-5

Similar Items